Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling.

Meier, Markus; Klein, Harald H; Kramer, Jan; Drenckhan, Maren; Schütt, Morten

Meier, Markus; Klein, Harald H; Kramer, Jan; Drenckhan, Maren; Schütt, Morten.

Affiliation

Meier M; Department of Internal Medicine I, University of Lübeck, Ratzeburger Allee 160, D- 23538 Lübeck, Germany. markus.meier@uni-luebeck.de

J Endocrinol ; 193(1): 45-51, 2007 Apr.

Article in En | MEDLINE | ID: mdl-17400802

Subject(s)

Acrylates/pharmacology; Calpain/antagonists & inhibitors; Glycogen/biosynthesis; Insulin/metabolism; Liver/metabolism; Signal Transduction; Androstadienes/pharmacology; Cell Line, Tumor; Humans; Insulin/pharmacology; Insulin Receptor Substrate Proteins; Liver/drug effects; Phosphatidylinositol 3-Kinases/metabolism; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins/metabolism; Protein Binding/drug effects; Protein Serine-Threonine Kinases/metabolism; Protein Tyrosine Phosphatases/metabolism; Receptor, Insulin/metabolism; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Wortmannin

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Acrylates / Calpain / Signal Transduction / Glycogen / Insulin / Liver Limits: Humans Language: En Journal: J Endocrinol Year: 2007 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links